Status:
UNKNOWN
The Association of Costimulatory Molecules and PPAR-polymorphisms With Autoimmune Thyroid Disease in Taiwan
Lead Sponsor:
Taipei Medical University WanFang Hospital
Conditions:
AITd Patients With Different Polymorphisms
Eligibility:
All Genders
20+ years
Brief Summary
Autoimmune thyroid disease is the most common organ-specific autoimmune disease. AITD include Graves' disease and Hashimoto's thyroiditis. Although the pathogenesis of AITD remains unclear, it is gene...
Detailed Description
Autoimmune thyroid disease is the most common organ-specific autoimmune disease. AITD include Graves' disease and Hashimoto's thyroiditis. Although the pathogenesis of AITD remains unclear, it is gene...
Eligibility Criteria
Inclusion
- Autoimmune thyroid patients
- patients who cut Nodular Goiter in Wanfang Hospital
Exclusion
- none
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01260532
Start Date
July 1 2009
End Date
June 1 2019
Last Update
December 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University - WanFang Hospital
Taipei, Taiwan